UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 208

Sortiert nach

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

Lancet neurology, 2020-05, Vol.19 (5), p.452-461

2020

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Movement disorders, 2010-11, Vol.25 (15), p.2649-2653

2010

Link zum Volltext

Verfügbarkeit prüfen

Physiotherapy for Parkinson's disease: a comparison of techniques

Cochrane database of systematic reviews, 2014-06, Vol.2014 (6), p.CD002815-CD002815

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)

Health technology assessment (Winchester, England), 2016-08, Vol.20 (63), p.1-96

2016

Link zum Volltext

Verfügbarkeit prüfen

Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

Movement disorders, 2007-12, Vol.22 (16), p.2398-2404

2007

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease

Movement disorders, 2011-03, Vol.26 (4), p.587-598

2011

Link zum Volltext

Verfügbarkeit prüfen

Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

Movement disorders, 2006-11, Vol.21 (11), p.1844-1850

2006

Link zum Volltext

Verfügbarkeit prüfen

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease

Trials, 2017-08, Vol.18 (1), p.397-397, Article 397

2017

Link zum Volltext

Verfügbarkeit prüfen

Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009–2013

Parkinsonism & related disorders, 2015-05, Vol.21 (5), p.449-454

2015

Link zum Volltext

Verfügbarkeit prüfen

Botulinum toxins for the prevention of migraine in adults

Cochrane database of systematic reviews, 2018-06, Vol.6 (6), p.CD011616

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Cochrane database of systematic reviews, 2011-11 (11), p.CD008454

2011

Link zum Volltext

Verfügbarkeit prüfen

Physiotherapy versus placebo or no intervention in Parkinson's disease

Cochrane database of systematic reviews, 2013-09, Vol.2013 (9), p.CD002817-CD002817

2013

Link zum Volltext

Verfügbarkeit prüfen

Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis

BMJ (Online), 2012-08, Vol.345 (7872), p.e5004

International edition, 2012

Link zum Volltext

Verfügbarkeit prüfen

Initial drug treatment in Parkinson's disease

BMJ (Online), 2015-09, Vol.351, p.h4669

2015

Link zum Volltext

Verfügbarkeit prüfen

Subjective Experiences of Speech and Language Therapy in Patients with Parkinson’s Disease: A Pilot Study

Rehabilitation research and practice, 2015-01, Vol.2015, p.839895-11

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost‐Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease

Movement disorders, 2021-09, Vol.36 (9), p.2136-2143

2021

Link zum Volltext

Verfügbarkeit prüfen

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial

JAMA neurology, 2016-03, Vol.73 (3), p.291

2016

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of paramedical therapies for Parkinson's disease

Movement disorders, 2002-09, Vol.17 (5), p.984-991

2002

Link zum Volltext

Verfügbarkeit prüfen

Physiotherapy versus placebo or no intervention in Parkinson's disease

Cochrane database of systematic reviews, 2012-07 (7), p.CD002817

2012

Link zum Volltext

Verfügbarkeit prüfen

Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

Movement disorders, 2008-04, Vol.23 (6), p.784-789

Clarke, Carl E.

2008

Link zum Volltext

Verfügbarkeit prüfen

Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease

BMJ open, 2014-12, Vol.4 (12), p.e006434-e006434

2014

Link zum Volltext

Verfügbarkeit prüfen

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine

BMJ open, 2019-07, Vol.9 (7), p.e027953-e027953

2019

Link zum Volltext

Verfügbarkeit prüfen

Authors' reply to Braithwaite and Elrington

BMJ (Online), 2015-11, Vol.351, p.h5846

2015

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Subjective Experiences of Speech and Language Therapy in Patients with Parkinson’s Disease: A Pilot Study”

Rehabilitation research and practice, 2016-01, Vol.2016, p.1654282-1

2016

Link zum Volltext

Verfügbarkeit prüfen

Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel

Journal of Parkinson's disease, 2024-01, Vol.14 (1), p.53-63

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(139)
Humans
(114)
Life Sciences & Biomedicine
(112)
Parkinson's Disease
(63)
Neurology
(59)
Female
(48)
Neurosciences & Neurology
(44)
Male
(43)
Movement Disorders
(37)
Clinical Neurology
(34)
Parkinson Disease - Drug Therapy
(34)
Middle Aged
(32)
General & Internal Medicine
(30)
Biological And Medical Sciences
(29)
Adult
(28)
Parkinson Disease
(28)
Randomized Controlled Trials As Topic
(28)
Aged
(27)
Medical Sciences
(27)
Medicine, General & Internal
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

Physiotherapy for Parkinson's disease: a comparison of techniques

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)

Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease

Development of dyskinesias in a 5-year trial of ropinirole and L-dopa

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease

Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009–2013

Botulinum toxins for the prevention of migraine in adults

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

Physiotherapy versus placebo or no intervention in Parkinson's disease

Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis

Initial drug treatment in Parkinson's disease

Subjective Experiences of Speech and Language Therapy in Patients with Parkinson’s Disease: A Pilot Study

Cost‐Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease

Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial

Systematic review of paramedical therapies for Parkinson's disease

Physiotherapy versus placebo or no intervention in Parkinson's disease

Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine

Authors' reply to Braithwaite and Elrington

Corrigendum to “Subjective Experiences of Speech and Language Therapy in Patients with Parkinson’s Disease: A Pilot Study”

Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel

Suchergebnisse filtern